More about
Bleomycin
News
August 09, 2024
5 min read
Save
Case study: Orbital lymphangioma manifests postpartum
News
February 07, 2020
2 min read
Save
Bleomycin regimen for germ cell cancer linked to increased cardiovascular risk
A regimen of bleomycin, etoposide and cisplatin for male germ cell cancer appeared associated with substantially increased risk for cardiovascular disease less than 1 year after treatment and mildly increased risk after 10 years of follow-up, according to results of a retrospective Danish study published in Journal of Clinical Oncology.